IPRO-Δ provides a data-driven method to anticipate OS treatment effects beyond traditional measures”— Felix Baldauf-Lenschen, CEO of Altis LabsCHICAGO, IL, UNITED STATES, June 3, 2025 ...

Provided by Business Wire May 30, 2025, 12:00:00 PM. Ontada Unveils Comprehensive Data on Social Determinants of Health and Outcomes of Early-Onset Colorectal Cancer at ASCO.

Massive Bio showcases AI oncology solutions and clinical trial tech at ASCO25, highlighting real-world data and patient-matching innovations.